A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
about
Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceEquilibrative nucleoside transporters-A review.A novel non-natural nucleoside that influences P-glycoprotein activity and mediates drug resistanceDeoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study.Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removalContribution of tumoral and host solute carriers to clinical drug response.[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.The role of transporters in the toxicity of nucleoside and nucleotide analogs.Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.Genetic and epigenetic variants contributing to clofarabine cytotoxicity.New insights into the synergism of nucleoside analogs with radiotherapyThe Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges.Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug-Drug InteractionsEfficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.
P2860
Q27488307-44337801-7ECD-48E7-9B30-40867F468077Q30244329-25AA6C4E-308B-4F23-B1D1-B3EF2DF01FBBQ30503884-F4126B57-9706-4C04-B568-9A2A056FAFBBQ34159634-C16ED0D6-F357-40E4-A81C-7D39751375BAQ35066350-885247B1-2F47-48B7-B30F-8586941A1320Q35572057-76E2F9D6-0F84-4F06-A8AB-30F351AA84C4Q35848805-32055397-4DDB-4E58-9281-7DCFDDFDEB53Q35946876-473EF39B-A0EE-4AF6-85AA-03D3F6ABF16BQ36821582-E33F179B-EE00-4857-8110-B14CB5E50180Q36921993-F3E35F3F-C4C2-429C-B660-2B653FBB3D5AQ37064875-8C8D905B-F542-40E7-B0EC-32AFD0004158Q37153800-2D0881DC-5A3C-4454-BA54-08CA717B8784Q38143241-64482F3D-43C7-42BE-B94B-B4169315BDBFQ38686607-0A61747A-9B3B-40F7-A22B-6BC078CA9ACCQ40829113-C4E2B0A6-1A1F-4243-A04D-0F5CA82C2D85Q41365886-71F21BA7-A686-4B79-8053-06CD9B5680FFQ41898186-D88273E6-22B6-4A64-9E98-FCB930B247F7
P2860
A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A comparison of the transporta ...... hree model expression systems.
@en
type
label
A comparison of the transporta ...... hree model expression systems.
@en
prefLabel
A comparison of the transporta ...... hree model expression systems.
@en
P2093
P356
P1476
A comparison of the transporta ...... hree model expression systems.
@en
P2093
Amy M L Ng
Carol E Cass
Delores A Mowles
James D Young
Karen M King
Mark F Vickers
Sylvia Y Yao
Thach Lang
Tracey E Tackaberry
Vijaya L Damaraju
P304
P356
10.1124/MOL.105.015768
P577
2005-10-18T00:00:00Z